Press Releases

HELSINKI, Jan. 13, 2020 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, has appointed Sally Langa as Head of US Sales. The new role will enable Nanoform to continue its rapid growth with a strengthened presence in the US market.As Head of US Sales, Sally Langa will drive

STOCKHOLM, Jan. 13, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the last patient has now been included in the pivotal IsoConDa study. Thus, all 300 patients have been included and the study is expected to show top-line results during Q2 2020."This is a true milestone for Sedana Medical. It is extremely gratifyin

TUCSON, Ariz., Jan. 13, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced preliminary financial results for the quarter and year ending December 31, 2019. Highlights for the fourth quarter and full-year 2019 are presented below.

VENTURA, Calif., Jan. 13, 2020 /PRNewswire/ -- Pet Wellness Direct reports that according to the American Veterinary Medical Association, cancer is now the #1 killer of dogs and cats."Cancer rates in pets are alarmingly high, even in young pets," says Doctor of Veterinary Medicine Shawn Messonnier, founder of Paws & Claws Animal Hospital in

SUZHOU, China, Jan. 12, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced with Eli Lilly and Company ("Lilly", NYSE: LLY) the results of a Phase 3 study in C

LUND, Sweden, Jan. 13, 2020 /PRNewswire/ --  Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced a business update for the fourth quarter 2019 and preliminary, unaudited key financials for its financial year 2019. The company will be participating in the JP Morgan Global Healthcare Conference

SINGAPORE, Jan. 12, 2020 /PRNewswire/ -- Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis' first-wave biosimilar candidates in Taiwan and Hong Kong.

SHANGHAI, Jan. 12, 2020 /PRNewswire/ -- According to a forecast from CIConsulting, the revenue of China's medical equipment and manufacturing industry will reach CNY327.4 billion in 2019, the average annual compound growth rate over the next five years will be about 8.15%, and the market will reach

MADISON, Wis., Jan. 12, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $294 million and $296 million for the fourth quarter ended Dec. 31, 2019.

SAN DIEGO, Jan. 12, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today provided an update on its business performance, including preliminary net product sales results for 2019, and key commercial and clinical development milestones for 2020. Kevin Gorman, Chief Executive Officer of Neurocrine Biosciences, will discu